BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. Cancer Sci 2020;111:3142-54. [PMID: 32536012 DOI: 10.1111/cas.14532] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Abdelaal MR, Soror SH, Elnagar MR, Haffez H. Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy. Molecules 2021;26:506. [PMID: 33477997 DOI: 10.3390/molecules26020506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
3 Marzano F, Caratozzolo MF, Pesole G, Sbisà E, Tullo A. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines 2021;9:241. [PMID: 33673719 DOI: 10.3390/biomedicines9030241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol 2021;22:e358-68. [PMID: 34339656 DOI: 10.1016/S1470-2045(21)00343-0] [Reference Citation Analysis]
5 Winitchaikul T, Sawong S, Surangkul D, Srikummool M, Somran J, Pekthong D, Kamonlakorn K, Nangngam P, Parhira S, Srisawang P. Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells. PLoS One 2021;16:e0254392. [PMID: 34343190 DOI: 10.1371/journal.pone.0254392] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers (Basel) 2021;13:5106. [PMID: 34680255 DOI: 10.3390/cancers13205106] [Reference Citation Analysis]
7 Zhang W, Pan R, Lu M, Zhang Q, Lin Z, Qin Y, Wang Z, Gong S, Lin H, Chong S, Lu L, Liao W, Lu X. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway. Oncogene 2021;40:6369-80. [PMID: 34588619 DOI: 10.1038/s41388-021-02029-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li R, He C, Shen L, Wang S, Shen Y, Feng F, Zhang J, Zheng J. NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression. Oncol Lett 2021;22:782. [PMID: 34594423 DOI: 10.3892/ol.2021.13043] [Reference Citation Analysis]
9 Micallef I, Baron B. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Noncoding RNA 2021;7:24. [PMID: 33807355 DOI: 10.3390/ncrna7020024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. Cancer Sci 2020;111:3142-54. [PMID: 32536012 DOI: 10.1111/cas.14532] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
11 Mitchel J, Bajaj P, Patil K, Gunnarson A, Pourchet E, Kim YN, Skolnick J, Pai SB. Computational Identification of Stearic Acid as a Potential PDK1 Inhibitor and In Vitro Validation of Stearic Acid as Colon Cancer Therapeutic in Combination with 5-Fluorouracil. Cancer Inform 2021;20:11769351211065979. [PMID: 34924752 DOI: 10.1177/11769351211065979] [Reference Citation Analysis]
12 Kurasaka C, Ogino Y, Sato A. Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells. Int J Mol Sci 2021;22:2916. [PMID: 33805673 DOI: 10.3390/ijms22062916] [Reference Citation Analysis]
13 Jiang Z, Hou Z, Liu W, Yu Z, Liang Z, Chen S. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance. Bioengineered 2022;13:810-23. [PMID: 34974791 DOI: 10.1080/21655979.2021.2012952] [Reference Citation Analysis]
14 Pidíková P, Herichová I. miRNA Clusters with Up-Regulated Expression in Colorectal Cancer. Cancers (Basel) 2021;13:2979. [PMID: 34198662 DOI: 10.3390/cancers13122979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Cirillo M, Giacomini D. Molecular Delivery of Cytotoxic Agents via Integrin Activation. Cancers (Basel) 2021;13:299. [PMID: 33467465 DOI: 10.3390/cancers13020299] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Han JH, Kim M, Kim HJ, Jang SB, Bae SJ, Lee IK, Ryu D, Ha KT. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil. Int J Mol Sci 2021;22:5406. [PMID: 34065602 DOI: 10.3390/ijms22105406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Liu F, Li R, Zhang R, He M, Zhang Y. Knockdown of circNRIP1 sensitizes colorectal cancer to 5‑FU via sponging miR‑532‑3p. Oncol Rep 2021;46:218. [PMID: 34396434 DOI: 10.3892/or.2021.8169] [Reference Citation Analysis]
18 Chalabi-Dchar M, Fenouil T, Machon C, Vincent A, Catez F, Marcel V, Mertani HC, Saurin JC, Bouvet P, Guitton J, Venezia ND, Diaz JJ. A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate. NAR Cancer 2021;3:zcab032. [PMID: 34409299 DOI: 10.1093/narcan/zcab032] [Reference Citation Analysis]
19 Zhang X, Li Q, Du A, Li Y, Shi Q, Chen Y, Zhao Y, Wang B, Pan F. Adipocytic Glutamine Synthetase Upregulation via Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer. Front Oncol 2021;11:748730. [PMID: 34712612 DOI: 10.3389/fonc.2021.748730] [Reference Citation Analysis]
20 Kang YH, Lee JS, Lee NH, Kim SH, Seo CS, Son CG. Coptidis Rhizoma Extract Reverses 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells via Modulation of Thymidylate Synthase. Molecules 2021;26:1856. [PMID: 33806077 DOI: 10.3390/molecules26071856] [Reference Citation Analysis]
21 Liu Y, Ao X, Ji G, Zhang Y, Yu W, Wang J. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer. Front Oncol 2021;11:768918. [PMID: 34912714 DOI: 10.3389/fonc.2021.768918] [Reference Citation Analysis]
22 Hodroj K, Barthelemy D, Lega JC, Grenet G, Gagnieu MC, Walter T, Guitton J, Payen-Gay L. Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature. ESMO Open 2021;6:100125. [PMID: 33895696 DOI: 10.1016/j.esmoop.2021.100125] [Reference Citation Analysis]
23 Gu Y, Zhang L, Yang H, Zhuang J, Sun Z, Guo J, Guan M. Nanosecond pulsed electric fields impair viability and mucin expression in mucinous colorectal carcinoma cell. Bioelectrochemistry 2021;141:107844. [PMID: 34052542 DOI: 10.1016/j.bioelechem.2021.107844] [Reference Citation Analysis]
24 Palassin P, Lapierre M, Pyrdziak S, Wagner A, Stehle R, Corsini C, Duffour J, Bonnet S, Boulahtouf A, Rodriguez C, Ho-Pun-Cheung A, Lopez-Crapez E, Boissière-Michot F, Bibeau F, Thezenas S, Elarouci N, Selves J, Hoffmann JS, Roepman P, Mazard T, Buhard O, Duval A, Jalaguier S, Cavaillès V, Castet-Nicolas A. A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors. Cancers (Basel) 2021;13:4449. [PMID: 34503257 DOI: 10.3390/cancers13174449] [Reference Citation Analysis]
25 Sbirkov Y, Molander D, Milet C, Bodurov I, Atanasov B, Penkov R, Belev N, Forraz N, McGuckin C, Sarafian V. A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening. Front Bioeng Biotechnol 2021;9:755563. [PMID: 34869264 DOI: 10.3389/fbioe.2021.755563] [Reference Citation Analysis]
26 Wang Y, Cui X, Ma S, Zhang H. Decreased expression of miR-3135b reduces sensitivity to 5-fluorouracil in colorectal cancer by direct repression of PIM1. Exp Ther Med 2021;22:1151. [PMID: 34504596 DOI: 10.3892/etm.2021.10585] [Reference Citation Analysis]
27 Pan W, Wang K, Li J, Li H, Cai Y, Zhang M, Wang A, Wu Y, Gao W, Weng W. Restoring HOXD10 Exhibits Therapeutic Potential for Ameliorating Malignant Progression and 5-Fluorouracil Resistance in Colorectal Cancer. Front Oncol 2021;11:771528. [PMID: 34790580 DOI: 10.3389/fonc.2021.771528] [Reference Citation Analysis]
28 Abdel-latif RT, Wadie W, Abdel-mottaleb Y, Abdallah DM, El-maraghy NN, El-abhar HS. Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model. Saudi Pharmaceutical Journal 2021. [DOI: 10.1016/j.jsps.2021.12.009] [Reference Citation Analysis]
29 Chu H, Han N, Xu J. CMPK1 Regulated by miR-130b Attenuates Response to 5-FU Treatment in Gastric Cancer. Front Oncol 2021;11:637470. [PMID: 33816278 DOI: 10.3389/fonc.2021.637470] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Wu KL, Lee KC, Yen CK, Chen CN, Chang SF, Huang WS. Visfatin and Resveratrol Differentially Regulate the Expression of Thymidylate Synthase to Control the Sensitivity of Human Colorectal Cancer Cells to Capecitabine Cytotoxicity. Life (Basel) 2021;11:1371. [PMID: 34947902 DOI: 10.3390/life11121371] [Reference Citation Analysis]
31 Chen Y, Zhou YW, Cheng K, Li ZP, Luo DY, Qiu M, Li Q, Wang X, Shen YL, Cao D, Yang Y, Bi F, Liu JY, Gou HF. Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study. Oncologist 2021;26:e1320-6. [PMID: 33830591 DOI: 10.1002/onco.13778] [Reference Citation Analysis]
32 Yang H, Xie S, Liang B, Tang Q, Liu H, Wang D, Huang G. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil. J Cancer 2021;12:4862-72. [PMID: 34234856 DOI: 10.7150/jca.58846] [Reference Citation Analysis]
33 Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, Yi P, Pan Q, Rao S, Han Y, Tang Y, Su M, Luo X, Yang Y, Chen X, Yang L, Zhou Y, Liao Q. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity. Oncogene 2022. [PMID: 34997215 DOI: 10.1038/s41388-021-02148-y] [Reference Citation Analysis]
34 Mosca L, Pagano M, Borzacchiello L, Mele L, Russo A, Russo G, Cacciapuoti G, Porcelli M. S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation. Int J Mol Sci 2021;22:9286. [PMID: 34502219 DOI: 10.3390/ijms22179286] [Reference Citation Analysis]
35 Olivera GC, Ross EC, Peuckert C, Barragan A. Blood-brain barrier-restricted translocation of Toxoplasma gondii from cortical capillaries. Elife 2021;10:e69182. [PMID: 34877929 DOI: 10.7554/eLife.69182] [Reference Citation Analysis]
36 Siri M, Behrouj H, Dastghaib S, Zamani M, Likus W, Rezaie S, Hudecki J, Khazayel S, Łos MJ, Mokarram P, Ghavami S. Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition. Arch Immunol Ther Exp (Warsz) 2021;69:26. [PMID: 34536148 DOI: 10.1007/s00005-021-00629-2] [Reference Citation Analysis]
37 Fu Y, Huang R, Li J, Xie X, Deng Y. LncRNA ENSG00000254615 Modulates Proliferation and 5-FU Resistance by Regulating p21 and Cyclin D1 in Colorectal Cancer. Cancer Invest 2021;:1-32. [PMID: 33938344 DOI: 10.1080/07357907.2021.1923727] [Reference Citation Analysis]